Please login to the form below

Not currently logged in
Email:
Password:

AndroGel

This page shows the latest AndroGel news and features for those working in and with pharma, biotech and healthcare.

AbbVie sales jump on strong Humira gains

AbbVie sales jump on strong Humira gains

Among other products, HIV therapy Kaletra (lopinavir/ ritonavir) rose 1.1 per cent to $278m, while revenue from testosterone replacement therapy AndroGel fell 6.5 per cent to $258m.

Latest news

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Pharma deals in May 2015 Pharma deals in May 2015

    This is not the first such case for Teva, as the FTC also filed suit last September for an alleged pay for delay relating to AndroGel.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics